Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Promising Results in Phase 1 Study of Novel Menin Inhibitor for Aggressive Leukemia

The Menin/KMT2A interaction is a therapeutic target in human MN1

Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023

Targeting the undruggable: menin inhibitors ante portas

Current status and future perspectives in targeted therapy of NPM1-mutated AML

MD Anderson Research Highlights for February 22, 2023

Models of pediatric acute megakaryoblastic leukemia lead to new potential therapies

Cancers, Free Full-Text

Acute promyelocytic leukemia - Wikipedia

Revumenib Shows Promise for Advanced Acute Myeloid Leukemia - NCI

Acute lymphoblastic leukemia - Wikipedia

The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target

Rho GTPase signaling in cancer progression and dissemination

Chronic Lymphocytic Leukemia - Ask Hematologist

A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler - BroadcastMed